KCTD19

gene
On this page

Also known as FLJ40162

Summary

KCTD19 (potassium channel tetramerization domain containing 19, HGNC:24753) is a protein-coding gene on chromosome 16q22.1, encoding BTB/POZ domain-containing protein KCTD19 (Q17RG1). Transcription regulator which is essential for male fertility and for the completion of meiotic prophase in spermatocytes.

Predicted to enable identical protein binding activity. Predicted to be involved in male meiotic nuclear division. Predicted to be located in nucleus.

Source: NCBI Gene 146212 — RefSeq curated summary.

At a glance

  • GWAS associations: 10
  • Clinical variants (ClinVar): 135 total — 1 likely-pathogenic
  • MANE Select transcript: NM_001100915

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:24753
Approved symbolKCTD19
Namepotassium channel tetramerization domain containing 19
Location16q22.1
Locus typegene with protein product
StatusApproved
AliasesFLJ40162
Ensembl geneENSG00000168676
Ensembl biotypeprotein_coding
OMIM619943
Entrez146212

Gene structure

Transcript identifiers

Ensembl transcripts: 11 — 4 protein_coding, 4 retained_intron, 2 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay

ENST00000304372, ENST00000561625, ENST00000562721, ENST00000562841, ENST00000562860, ENST00000566295, ENST00000566392, ENST00000567976, ENST00000568736, ENST00000569333, ENST00000570049

RefSeq mRNA: 1 — MANE Select: NM_001100915 NM_001100915

CCDS: CCDS42179

Canonical transcript exons

ENST00000304372 — 16 exons

ExonStartEnd
ENSE000014805656728943267289682
ENSE000025837236732670567326741
ENSE000034651706730442167304571
ENSE000034866726732058967320885
ENSE000035200936729088567290986
ENSE000035356336729750367297663
ENSE000035408426729164667291837
ENSE000035435556729615967296259
ENSE000035507296729526367295405
ENSE000035819466729354467294171
ENSE000036139626730314667303337
ENSE000036460956729497367295056
ENSE000036483146729936367299573
ENSE000036620116729458067294694
ENSE000036655916729130967291463
ENSE000036862016730179167301922

Expression profiles

Bgee: expression breadth ubiquitous, 147 present calls, max score 95.16.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.3292 / max 120.4397, expressed in 124 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
1577630.2944115
1577650.01806
1577620.01003
1577640.00682

Top tissues by expression

254 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right testisUBERON:000453495.16gold quality
left testisUBERON:000453395.01gold quality
testisUBERON:000047391.46gold quality
adult organismUBERON:000702384.15gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099180.27gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047379.40gold quality
upper arm skinUBERON:000426375.70gold quality
kidney epitheliumUBERON:000481968.21gold quality
vastus lateralisUBERON:000137967.00gold quality
quadriceps femorisUBERON:000137766.58gold quality
cardiac muscle of right atriumUBERON:000337966.56gold quality
left ventricle myocardiumUBERON:000656666.28gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451165.64gold quality
ventricular zoneUBERON:000305364.97gold quality
biceps brachiiUBERON:000150764.30gold quality
nasal cavity epitheliumUBERON:000538463.74gold quality
spermCL:000001962.31gold quality
skeletal muscle tissue of biceps brachiiUBERON:000450261.69gold quality
stromal cell of endometriumCL:000225560.82gold quality
putamenUBERON:000187460.68gold quality
deciduaUBERON:000245060.11gold quality
islet of LangerhansUBERON:000000660.07gold quality
muscle tissueUBERON:000238559.06gold quality
adrenal tissueUBERON:001830359.05gold quality
deltoidUBERON:000147658.84gold quality
skeletal muscle tissueUBERON:000113458.29gold quality
caudate nucleusUBERON:000187358.25gold quality
layer of synovial tissueUBERON:000761658.22gold quality
sural nerveUBERON:001548858.08silver quality
substantia nigra pars compactaUBERON:000196557.98gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes3.70

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 2)

  • Biallelic variants in KCTD19 associated with male factor infertility and oligoasthenoteratozoospermia. (PMID:37192818)
  • Homozygous nonsense variants of KCTD19 cause male infertility in humans and mice. (PMID:37257643)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
mus_musculusKctd19ENSMUSG00000051648
rattus_norvegicusKctd19ENSRNOG00000016760
drosophila_melanogastertwzFBGN0034636
caenorhabditis_elegansF32B4.5WBGENE00009315

Paralogs (13): KCTD1 (ENSG00000134504), KCTD14 (ENSG00000151364), KCTD15 (ENSG00000153885), KCTD18 (ENSG00000155729), KCTD6 (ENSG00000168301), KCTD12 (ENSG00000178695), KCTD4 (ENSG00000180332), KCTD16 (ENSG00000183775), KCTD8 (ENSG00000183783), KCTD21 (ENSG00000188997), KCNRG (ENSG00000198553), KCTD11 (ENSG00000213859), KCTD7 (ENSG00000243335)

Protein

Protein identifiers

BTB/POZ domain-containing protein KCTD19Q17RG1 (reviewed: Q17RG1)

Alternative names: Potassium channel tetramerization domain-containing protein 19

All UniProt accessions (5): Q17RG1, H3BVC0, J3KRQ9, J3KSZ9, J3QKV2

UniProt curated annotations — full annotation on UniProt →

Function. Transcription regulator which is essential for male fertility and for the completion of meiotic prophase in spermatocytes. Regulates progression of the pachytene stage of meiotic prophase and promotes the transcriptional activation activity ZNF541. Required for the organization of chromosomes during metaphase I.

Subunit / interactions. Identified in a complex with ZNF541, HDAC1 and HSPA2. Identified in a complex with ZNF541 and HDAC1. Identified in a complex with HDAC1, HDAC2, DNTTIP1 and ZNF541.

Subcellular location. Nucleus.

RefSeq proteins (1): NP_001094385* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR003131T1-type_BTBDomain
IPR011333SKP1/BTB/POZ_sfHomologous_superfamily

Pfam: PF02214

UniProt features (8 total): domain 2, chain 1, region of interest 1, compositionally biased region 1, modified residue 1, sequence variant 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q17RG1-F166.530.31

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 270

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 30 (showing top): chr16q22, GOBP_MALE_GAMETE_GENERATION, GOBP_ORGANELLE_FISSION, GOBP_PROTEIN_HOMOOLIGOMERIZATION, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOBP_MEIOTIC_CELL_CYCLE_PROCESS, GOBP_MEIOTIC_CELL_CYCLE, GOBP_CELL_CYCLE_PROCESS, GOBP_MALE_MEIOTIC_NUCLEAR_DIVISION, GOBP_PROTEIN_COMPLEX_OLIGOMERIZATION, ZNF2_TARGET_GENES, ZNF274_TARGET_GENES, ZNF512_TARGET_GENES, ZNF843_TARGET_GENES, GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_DN

GO Biological Process (5): male meiotic nuclear division (GO:0007140), spermatogenesis (GO:0007283), cell differentiation (GO:0030154), protein homooligomerization (GO:0051260), meiotic cell cycle (GO:0051321)

GO Molecular Function (2): identical protein binding (GO:0042802), protein binding (GO:0005515)

GO Cellular Component (1): nucleus (GO:0005634)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
male gamete generation2
meiotic nuclear division2
meiotic cell cycle1
developmental process involved in reproduction1
cellular developmental process1
protein complex oligomerization1
cell cycle1
sexual reproduction1
reproductive process1
protein binding1
binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

3197 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
KCTD19DNTTIP1Q9H147664
KCTD19KCTD3Q9Y597645
KCTD19KCTD20Q7Z5Y7643
KCTD19BTBD10Q9BSF8641
KCTD19SHKBP1Q8TBC3615
KCTD19KCTD18Q6PI47603
KCTD19PLEKHG4Q58EX7585
KCTD19HDAC1Q13547558
KCTD19MIDEASQ6PJG2547
KCTD19TNFAIP1Q13829541
KCTD19MEIKINA0A087WXM9535
KCTD19KCTD8Q6ZWB6533
KCTD19HSPA2P54652529
KCTD19KCTD5Q9NXV2515
KCTD19KCTD9Q7L273514

IntAct

9 interactions, top by confidence:

ABTypeScore
KCTD19psi-mi:“MI:0915”(physical association)0.560
KCTD19psi-mi:“MI:0915”(physical association)0.560
ZSCAN22KCTD19psi-mi:“MI:0915”(physical association)0.560
DYRK1ATEX13Dpsi-mi:“MI:0914”(association)0.350
KCTD19ECT2Lpsi-mi:“MI:0914”(association)0.350
KCTD19ZSCAN22psi-mi:“MI:0915”(physical association)0.000

BioGRID (8): KCTD19 (Two-hybrid), ZSCAN22 (Two-hybrid), ECT2L (Affinity Capture-MS), KCTD15 (Affinity Capture-MS), KCTD19 (Affinity Capture-MS), KCTD19 (Affinity Capture-MS), KCTD19 (Affinity Capture-MS), KCTD19 (Affinity Capture-MS)

ESM2 similar proteins: A0A5K7RLP0, A1YEX3, A7YWH3, B1WBU4, O15151, O35618, O43298, O88850, P24278, P97303, Q01954, Q0V8G8, Q15916, Q17RG1, Q562E2, Q5RC05, Q5RDQ6, Q5SXH7, Q5TC79, Q5VYS8, Q5W0Q7, Q5XIN1, Q6ZPY5, Q6ZSB9, Q6ZU67, Q7ZUW7, Q7ZYI3, Q8BLK9, Q8BSV3, Q8IW35, Q8K088, Q8N680, Q8N7W2, Q8TCN5, Q8VHI4, Q8WW38, Q90W33, Q96BR9, Q96S38, Q99ME3

Diamond homologs: A3KMV1, A4IFB4, A5PKG7, A6H6X4, A7YWH3, A9ULR9, B1WC97, B5DEL1, D5SHR0, O70479, O88759, P0C5J9, P15388, P17971, P25122, P48547, P59994, P59995, Q03607, Q03719, Q09389, Q0VD00, Q0VFV7, Q13829, Q14681, Q17RG1, Q28DC9, Q2HJ48, Q2T9W0, Q2TUM3, Q3URF8, Q4G0X4, Q50H33, Q52PG9, Q54KH0, Q562E2, Q58DF7, Q5DTY9, Q5F3E8, Q5M956

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

135 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic1
Uncertain significance114
Likely benign6
Benign3

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
224816NM_001100915.3(KCTD19):c.215C>A (p.Thr72Asn)Likely pathogenic

SpliceAI

2903 predictions. Top by Δscore:

VariantEffectΔscore
16:67291461:CTT:Cacceptor_gain1.0000
16:67291464:C:CCacceptor_gain1.0000
16:67294574:GCTT:Gdonor_loss1.0000
16:67294578:A:ACdonor_gain1.0000
16:67294578:AC:Adonor_loss1.0000
16:67294578:ACTT:Adonor_gain1.0000
16:67294579:C:CTdonor_gain1.0000
16:67294579:CT:Cdonor_gain1.0000
16:67294579:CTT:Cdonor_gain1.0000
16:67294579:CTTC:Cdonor_gain1.0000
16:67294579:CTTCT:Cdonor_gain1.0000
16:67294581:T:TAdonor_gain1.0000
16:67294642:T:TAdonor_gain1.0000
16:67294690:ATGAC:Aacceptor_gain1.0000
16:67294691:TGAC:Tacceptor_gain1.0000
16:67294692:GAC:Gacceptor_gain1.0000
16:67294693:AC:Aacceptor_gain1.0000
16:67294693:ACC:Aacceptor_loss1.0000
16:67294694:CC:Cacceptor_gain1.0000
16:67294694:CCTG:Cacceptor_loss1.0000
16:67294695:C:CCacceptor_gain1.0000
16:67294696:T:Aacceptor_loss1.0000
16:67294705:C:Tacceptor_gain1.0000
16:67294971:A:ACdonor_gain1.0000
16:67294972:C:CCdonor_gain1.0000
16:67297498:CTTA:Cdonor_gain1.0000
16:67297501:A:ACdonor_gain1.0000
16:67297502:C:CCdonor_gain1.0000
16:67297502:CTGAG:Cdonor_gain1.0000
16:67299361:A:ACdonor_gain1.0000

AlphaMissense

6053 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
16:67320605:A:GL95P0.999
16:67320621:C:GA90P0.999
16:67320812:A:TV26D0.999
16:67295296:C:GR453T0.998
16:67303203:A:GW196R0.998
16:67303203:A:TW196R0.998
16:67320680:A:GL70P0.998
16:67320684:A:CY69D0.998
16:67320701:A:GF63S0.998
16:67320710:C:TG60D0.998
16:67320714:C:GD59H0.998
16:67320817:G:CF24L0.998
16:67320817:G:TF24L0.998
16:67320819:A:GF24L0.998
16:67320830:C:TG20E0.998
16:67320831:C:AG20W0.998
16:67320839:A:GF17S0.998
16:67295295:T:AR453S0.997
16:67295295:T:GR453S0.997
16:67304567:A:GL102P0.997
16:67320596:A:GL98S0.997
16:67320700:A:CF63L0.997
16:67320700:A:TF63L0.997
16:67320702:A:GF63L0.997
16:67320713:T:AD59V0.997
16:67320780:A:GS37P0.997
16:67320818:A:GF24S0.997
16:67295052:A:GW466R0.996
16:67295052:A:TW466R0.996
16:67295304:G:CN450K0.996

dbSNP variants (sampled 300 via entrez): RS1000129864 (16:67289884 C>T), RS1000217128 (16:67299927 C>T), RS1000297597 (16:67324985 G>C), RS1000314267 (16:67303931 T>C), RS1000428926 (16:67303533 C>G), RS1000482306 (16:67295276 G>A), RS1000588618 (16:67318997 T>G), RS1000625039 (16:67294753 G>A,T), RS1000694982 (16:67296415 T>G), RS1000790994 (16:67308179 T>C), RS1000879868 (16:67309964 A>G), RS1000885876 (16:67307623 A>G), RS1001168679 (16:67317628 A>G), RS1001181530 (16:67300306 G>T), RS1001281986 (16:67325775 A>G)

Disease associations

OMIM: gene MIM:619943 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

10 associations (top):

StudyTraitp-value
GCST004063_120Waist circumference adjusted for body mass index2.000000e-08
GCST004063_121Waist circumference adjusted for body mass index5.000000e-06
GCST004500_115Waist circumference adjusted for BMI (adjusted for smoking behaviour)8.000000e-11
GCST004500_73Waist circumference adjusted for BMI (adjusted for smoking behaviour)7.000000e-09
GCST004501_98Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)2.000000e-11
GCST004501_99Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)2.000000e-09
GCST004504_70Waist circumference adjusted for BMI in non-smokers5.000000e-09
GCST004504_71Waist circumference adjusted for BMI in non-smokers9.000000e-07
GCST008158_46Body mass index1.000000e-06
GCST010002_113Refractive error2.000000e-14

EFO canonical traits (3, from GWAS)

EFO IDTrait name
EFO:0007789BMI-adjusted waist circumference
EFO:0004318smoking behavior
EFO:0004340body mass index

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

8 total (human), top 8 by PubMed support.

ChemicalActions (top 5)PubMed papers
aristolochic acid Iincreases expression1
entinostatincreases expression1
jinfukangincreases expression1
Sunitinibincreases expression1
Benzo(a)pyreneaffects methylation1
Tretinoinincreases expression1
Asbestos, Crocidoliteaffects methylation1
Cadmium Chlorideincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.